See a breakdown of Audience & Reach for Pembrolizumab for Patients with Advanced NSCLC and a Performance Status (PS) of 2: Results of the PePS2 Trial (BMIC-067)
See Brand Safety for Pembrolizumab for Patients with Advanced NSCLC and a Performance Status (PS) of 2: Results of the PePS2 Trial (BMIC-067)
How much does it cost to advertise on The Beacon (Video)?
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More